Introduction: Currently, extracellular matrix (ECM) patches are being investigated for rotator cuff repair augmentation [1] based on the concept that ECM patches may provide a natural and mechanically robust scaffold that reinforces the repair, guides host cell infiltration, and fosters formation of a functional tendon-bone bridge. To prevent or limit tendon retear, the ECM must maintain appropriate mechanical properties during the course of its remodeling. It has been shown that the host inflammatory response is a critical determinant of the remodeling outcome of an implanted ECM [2, 3]. Hence strategies to direct the inflammatory response to an ECM patch toward constructive remodeling and away from inflammation/degradation may enable the ECM patch to maintain adequate mechanical reinforcement of the repair throughout the healing process. Based on the well-appreciated role of hyaluronan (HA) as an anti-inflammatory agent [4], we postulate that selective incorporation and immobilization of HA into an ECM scaffold may be a strategy to promote an anti-inflammatory response to the ECM. Specifically, we have utilized tyramine-substituted hyaluronan (THA), which can be infiltrated into the ECM and then cross-linked by means of the tyramine adducts [5]. THA has been shown to be non-cytotoxic and biocompatible [5]. The low tyramine substitution rate (5%) sufficiently maintains the native structure of HA to allow recognition and binding by HA binding proteins (HABP), even after cross-linking into hydrogel form [5]. We reasoned that maintenance of HABP binding capacity by THA immobilized within an ECM could allow for a sustained presentation of the anti-inflammatory properties previously reported for individual HA chains. Specifically, in this study we hypothesize that the immobilization of THA in fascia ECM will reduce the inflammatory cell infiltrate as compared to water treated fascia. We further hypothesize that the inflammatory cell infiltrate will be lower in fascia grafts implanted at the shoulder than at the body wall in the canine model. Methods: Eight female beagles (4-6 years old) underwent bilateral implantation of fascia ECM grafts, treated with either water (controls) or low MW THA (57 kDa) at 7.3±1.7 μg/mg tissue weight, in the body wall and shoulder injury sites. Dogs were euthanized at 12 weeks, and fascia grafts from both sites, including surrounding tissues, were harvested en bloc and processed for histologic evaluation of inflammatory cell infiltrate.
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